ATE149837T1 - Gebrauch von oxatomide als antitussivum - Google Patents

Gebrauch von oxatomide als antitussivum

Info

Publication number
ATE149837T1
ATE149837T1 AT93111736T AT93111736T ATE149837T1 AT E149837 T1 ATE149837 T1 AT E149837T1 AT 93111736 T AT93111736 T AT 93111736T AT 93111736 T AT93111736 T AT 93111736T AT E149837 T1 ATE149837 T1 AT E149837T1
Authority
AT
Austria
Prior art keywords
oxatomide
antitussive
antitussive agent
agent
Prior art date
Application number
AT93111736T
Other languages
English (en)
Inventor
Piercarlo Braga
Original Assignee
Zoja Lab Chim Farm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoja Lab Chim Farm filed Critical Zoja Lab Chim Farm
Application granted granted Critical
Publication of ATE149837T1 publication Critical patent/ATE149837T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Dental Preparations (AREA)
AT93111736T 1992-07-30 1993-07-22 Gebrauch von oxatomide als antitussivum ATE149837T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI921866A IT1255639B (it) 1992-07-30 1992-07-30 Uso dell'oxatomide come agente antitosse

Publications (1)

Publication Number Publication Date
ATE149837T1 true ATE149837T1 (de) 1997-03-15

Family

ID=11363788

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93111736T ATE149837T1 (de) 1992-07-30 1993-07-22 Gebrauch von oxatomide als antitussivum

Country Status (6)

Country Link
US (1) US5422357A (de)
EP (1) EP0584535B1 (de)
JP (1) JPH06183977A (de)
AT (1) ATE149837T1 (de)
DE (1) DE69308680D1 (de)
IT (1) IT1255639B (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200641A (en) * 1976-12-21 1980-04-29 Janssen Pharmaceutica, N.V. 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives
US4829064A (en) * 1987-06-08 1989-05-09 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
WO1992004022A1 (en) * 1990-09-11 1992-03-19 Richardson Vicks Inc. Use of compositions containing 2-(6'-substituted-2'-naphthyl)-acetic acid derivatives for the treatment of respiratory disorders

Also Published As

Publication number Publication date
EP0584535B1 (de) 1997-03-12
ITMI921866A1 (it) 1994-01-30
EP0584535A1 (de) 1994-03-02
US5422357A (en) 1995-06-06
DE69308680D1 (de) 1997-04-17
IT1255639B (it) 1995-11-09
ITMI921866A0 (it) 1992-07-30
JPH06183977A (ja) 1994-07-05

Similar Documents

Publication Publication Date Title
ATE238790T1 (de) Verwendung von pramipexole als neuroschutzmittel
DE69322871D1 (de) Schlagzähmodifizierung von thermoplastiken
DE69431880D1 (de) Verwendung von (2-imidazolin-2-yl-amino) quinoxalinderivaten
ATE219938T1 (de) Neue 4-arylpiperazine und 4-arylpiperidine
DE69333153D1 (de) Lichtquelle
ATE156838T1 (de) Neue 7-beta-substituierte-4-aza-5-alpha-androstan-3- nen als inhibitoren 5-alpha-reduktases
DE69122217D1 (de) Sorption von Trialkylarsinen
BA98302A (bs) Bis-aza-biciklicna anksioliticka sredstva
DE59300287D1 (de) Verbesserte entsorgung von kontaminiertem bohrklein.
MX9302931A (es) Nuevas 4-aza-5&-colestan-onas 7b-substituidas como inhibidores de 5&-reductasa.
DE69313833D1 (de) Verringerung der Ausschaltszeit eines Ausgangsleistungstransistors
ES2157992T3 (es) Alcoxi-alquil-carbamatos de imidazo(1,2-a)piridinas.
KR950700339A (ko) 중합체 무두질제(polymeric tanning agents)
DE69328166D1 (de) Beseitigung von schmutzstoffen
NO944075L (no) Fremgangsmåte for fremstilling av (S)-3-amino-1-substituert pyrrolidiner
DE69325073D1 (de) Borazinderivate von Hydridopolysilazanpolymeren
DE68910676D1 (de) Verwendung von Creosot als antispastischer Wirkstoff.
ATA219592A (de) Erfassung der neigung von grabungen
DK0532629T3 (da) 1-Piperidinyl-alkanoylarylsulfonamid-derivater
NO934867D0 (no) Anvendelse av disulfonylmetaner for kontrollering av parasitter
FI944714L (fi) Beta-karboliinien uusi käyttö
DE69308680D1 (de) Gebrauch von Oxatomide als Antitussivum
DE59005647D1 (de) Verwendung von polyglykolethergemischen als antischaummittel.
DE69313554D1 (de) Verwendung von Tetrahydro-4-methyl-2-phenyl-2H-pyran als Riechstoff
DE69115116D1 (de) Heterocyclische NMDA Antagonisten.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties